The need for randomised controlled trials of isoniazid monoresistant tuberculosis treatment
- PMID: 28346171
- DOI: 10.1016/S1473-3099(17)30121-4
The need for randomised controlled trials of isoniazid monoresistant tuberculosis treatment
Comment on
-
Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis.Lancet Infect Dis. 2017 Feb;17(2):223-234. doi: 10.1016/S1473-3099(16)30407-8. Epub 2016 Nov 17. Lancet Infect Dis. 2017. PMID: 27865891
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources